Peer review reports
From: Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
Original Submission | ||
---|---|---|
3 Apr 2011 | Submitted | Original manuscript |
22 Apr 2011 | Reviewed | Reviewer Report - Henry Simpkins |
28 Apr 2011 | Reviewed | Reviewer Report - Robert Mandic |
6 May 2011 | Reviewed | Reviewer Report - Steven de Jong |
6 Jun 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 2 | ||
6 Jun 2011 | Submitted | Manuscript version 2 |
10 Jun 2011 | Reviewed | Reviewer Report - Henry Simpkins |
22 Jun 2011 | Reviewed | Reviewer Report - Steven de Jong |
25 Jun 2011 | Reviewed | Reviewer Report - Robert Mandic |
12 Jul 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 3 | ||
12 Jul 2011 | Submitted | Manuscript version 3 |
24 Jul 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 4 | ||
24 Jul 2011 | Submitted | Manuscript version 4 |
7 Aug 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 5 | ||
7 Aug 2011 | Submitted | Manuscript version 5 |
8 Aug 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 6 | ||
8 Aug 2011 | Submitted | Manuscript version 6 |
1 Sep 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 7 | ||
1 Sep 2011 | Submitted | Manuscript version 7 |
13 Sep 2011 | Author responded | Author comments - Ding Ma |
Resubmission - Version 8 | ||
13 Sep 2011 | Submitted | Manuscript version 8 |
Publishing | ||
21 Sep 2011 | Editorially accepted | |
21 Sep 2011 | Article published | 10.1186/1471-2407-11-399 |